Mainz Biomed N.V. (MYNZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2025 | 06-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 0 | 0 | 215 | 182 | 249 |
| Cost of Goods | N/A | N/A | 80 | 95 | 100 |
| Gross Profit | N/A | N/A | 135 | 87 | 149 |
| Operating Expenses | 0 | 0 | 6,805 | 5,822 | 8,175 |
| Operating Income | N/A | N/A | -6,590 | -5,641 | -7,926 |
| Other Income | 0 | 0 | 1,407 | -659 | -326 |
| Pre-tax Income | 0 | 0 | -5,183 | -6,300 | -8,252 |
| Net Income Continuous | N/A | N/A | -5,183 | -6,300 | -8,252 |
| Net Income | $N/A | $N/A | $-5,183 | $-6,300 | $-8,252 |
| EPS Basic Total Ops | N/A | N/A | -8.76 | -15.60 | -22.40 |
| EPS Basic Continuous Ops | N/A | N/A | -8.98 | -15.78 | -22.13 |
| EPS Diluted Total Ops | N/A | N/A | -8.76 | -15.60 | -22.40 |
| EPS Diluted Continuous Ops | N/A | N/A | -8.98 | -15.78 | -22.13 |
| EPS Diluted Before Non-Recurring Items | N/A | N/A | -9.60 | -15.60 | N/A |
| EBITDA(a) | $N/A | $N/A | $-6,386 | $-5,437 | $-7,755 |